The elimination of secretory leukocyte protease inhibitor (SLPI) after intravenous injection in dog and man

References

• Haendle H, Fritz H, Trautschold I, Werle E. Ueber einen hormonabhängigen Inhibitor für proteolytische Enzyme in männlichen accesso-rischen Geschlechtsdrüsen und im Sperma. Hoppe-Seyler's Z Physiol Chem 1965; 343: 185–8
   PubMedGoogle Scholar
• Hochstrasser K, Haendle H, Reichert R, Werle E. Ueber Vorkommen und Eigenschaften eines Proteasen-inhibitors in mennlichen Nasensekret. Hoppe-Seyler's Z Physiol Chem 1971; 352: 954–8
   PubMedGoogle Scholar
• Hochstrasser K, Haendle H, Reichert R, Werle E. Isolierung und Charakterisierung eines Proteasen-inhibitors aus mennlichen Bronchialsekret. Hoppe-Seyler's Z Physiol Chem 1972; 353: 221–6
   PubMedGoogle Scholar
• Ohlsson K, Tegner H, Fritz H, Schiessler H. Immunologic similarity between low molecular weight trypsin-chymotrypsin inhibitors from human bronchial secretion and seminal plasma. Hoppe-Seyler's Z Physiol Chem 1976; 357: 1241–4
   PubMedGoogle Scholar
• Schiessler H, Arnhold M, Ohlsson K, Fritz H. Inhibitors of acrosin and granulocyte proteinases from human genital tract secretions. Hoppe-Seyler's Z Physiol Chem 1976; 357: 1251–60
   PubMedGoogle Scholar
• Ohlsson K, Tegner H, Akesson U. Isolation and partial characterization of a low molecular weight acid stable protease inhibitor from human bronchial secretion. Hoppe-Seyler's Z Physiol Chem 1977; 358: 583–9
   PubMedGoogle Scholar
• Smith C E, Johnson P A. Human bronchial leukocyte proteinase inhibitor. Biochem J 1985; 225: 463–72
   PubMed Web of Science ®Google Scholar
• Boudier C, Carvallo D, Roitsch C, Bieth J G, Coutney M. Purification and characterization of human bronchial proteinase inhibitor. Arch Biochem Biophys 1987; 2(253)439–45
   Web of Science ®Google Scholar
• Haendle H, Ingrisch H, Werle E. Ueber einen neuen Trypsin-Chymotrypsin-Inhibitor im Cervix-sekret der Frau. Hoppe-Seyler's Z Physiol Chem 1970; 351: 545–6
   PubMedGoogle Scholar
• Wallner O, Fritz H. Characterization of an acid-stable proteinase inhibitor in human cervical mucus. Hoppe-Seyler's Z Physiol Chem 1974; 355: 709–15
   PubMedGoogle Scholar
• Schiessler H, Ohlsson K, Fritz H. The acid-stable proteinase inhibitor (antileukoprotease) of human cervical mucus. The Uterine Cervix in Reproduction Workshop Conference, Rottach-Egern. V Insler, G Bettendorf. Georg Thieme, Stuttgart 1977; 84–9
   Google Scholar
• Casslen B, Rosengren M, Ohlsson K. Localization and quantitation of a low molecular weight proteinase inhibitor, antileukoprotease, in the human uterus. Hoppe-Seyler's Z Physiol Chem 1981; 362: 953–61
   PubMedGoogle Scholar
• Ohlsson M, Rosengren M, Tegner H, Ohlsson K. Quantification of granulocyte elastase inhibitors in human mixed saliva and in pure parotid secretion. Hoppe-Seyler's Z Physiol Chem 1983; 364: 1323–8
   PubMedGoogle Scholar
• Ohlsson K, Rosengren M, Stetler G, Brewer M, Hale K K, Thompson R C. Structure, genomic organization, and tissue distribution of human secretory leukocyte-protease inhibitor (SLPI): a potent inhibitor of neutrophil elastase. Pulmonary Emphysema and Proteolysis, J C Taylor, C Mittman. Academic Press, London 1986; 307–22
   Google Scholar
• Thompson R C, Ohlsson K. Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase. Proc Natl Acad Sci USA 1986; 83: 6692–6
   PubMed Web of Science ®Google Scholar
• Stetler G, Brewer M T, Thompson R C. Isolation and sequence of a gene encoding a potent inhibitor of leukocyte proteases. Nucleic Acids Res 1986; 20(14)7883–96
   Web of Science ®Google Scholar
• Heinzel R, Appelhans H, Gassen H G, Seemuller U, Arnhold M, Fritz H, Lottspeich F, Wieden-Mann K, Machleidt W. The neutrophil elastase-cathepsin G inhibitor of human mucus tissues and secretions (antileukoproteas, HUSI-I): complete primary structure as revealed by protein and DNA sequencing. Pulmonary Emphysema and Proteolysis, J C Taylor, C Mittman. Academic Press, London 1986; 297–306
   Google Scholar
• Seemuller U, Arnhold M, Fritz H, Wiedenmann K, Machleidt W, Heinzel R, Appelhans H, Gassen H G, Lottspeich F. The acid-stable proteinase inhibitor of human mucous secretions (HUSI-I, antileukoprotease). FEBS Lett 1986; 199: 43–8
   PubMed Web of Science ®Google Scholar
• Tegner H. Quantitation of human granulocyte protease inhibitors in non-purulent bronchial lavage fluids. Acta Otolaryngol 1978; 85: 282–9
   PubMed Web of Science ®Google Scholar
• Tegner H, Ohlsson K. Localization of a low molecular weight protease inhibitor to tracheal and maxillary sinus mucosa. Hoppe-Seyler's Z Physiol Chem 1977; 358: 425–9
   PubMedGoogle Scholar
• Fryksmark U, Ohlsson K, Polling Å, Tegner H. Distribution of antileukoprotease and characterization of human antileukoprotease in serum. Ann Otol Rhinol Laryngol 1982; 91: 268–71
   PubMed Web of Science ®Google Scholar
• Ohlsson K, Fryksmark U, Ohlsson M, Tegner H. Interaction of granulocyte proteases with inhibitors in pulmonary diseases. Proteases-Potential Role in Health and Disease, W H Horl, A Heidland. Plenum Press, New York 1984; 299–312
   Google Scholar
• Kramps J A, Franken C, Meijer C JLM, Dijkman J H. Localization of low molecular weight protease inhibitor in serous secretory cells of the respiratory tract. J Histochem Cytochem 1981; 29: 712–9
   PubMed Web of Science ®Google Scholar
• Ohlsson K, Tegner H. Inhibition of elastase from granulocytes by the low molecular weight bronchial protease inhibitor. Scand J Clin Lab Invest 1976; 36: 437–45
   PubMed Web of Science ®Google Scholar
• Baugh R J, Travis J. Human leukocyte granule elastase: rapid isolation and characterization. J Biochem 1976; 15: 836–41
   Web of Science ®Google Scholar
• Fryksmark U, Ohlsson K, Rosengren M, Tegner H. A radioimmunoassay for measurement and characterization of human antileukoprotease in serum. Hoppe-Seyler's Z Physiol Chem 1981; 362: 1273–7
   PubMedGoogle Scholar
• Fraker P J, Speck J C. Protein and cell membrane iodinations with a sparingly soluble chloroamide, l,3,4,6-tetrachloro-3a, 6a- diphrenylglucoluril. Biochem Biophys Res Commun 1978; 80: 849–57
   PubMed Web of Science ®Google Scholar
• Mancini G, Carbonara A O, Hereman J P. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 1965; 2: 235–54
   PubMedGoogle Scholar
• Strober W, Waldman T A. The role of the kidney in the metabolism of plasma proteins. Nephron 1974; 13: 35–66
   PubMed Web of Science ®Google Scholar
• Fryksmark U, Prellner T, Tegner H, Ohlsson K. Studies on the role of antileukoprotease in respiratory tract diseases. Eur J Respir Dis 1984; 65: 201–9
   PubMedGoogle Scholar
• Kaller H, Patszschke K, Wegner L A, Horster F A. Pharmacokinetic observations following intravenous administration of radioactive labelled aprotinin in volunteers. Eur J Drug Met Pharma-kokinetics 1978; 2: 79–85
   Google Scholar
• Balldin G, Lasson A, Ohlsson K. Aprotinin turnover studies in dog and in man with severe acute pancreatitis. Hoppe-Seyler's Z Physiol Chem 1984; 365: 1417–23
   PubMedGoogle Scholar
• Eddeland A, Ohlsson K. Studies on the pancreatic secretory trypsin inhibitor in plasma and its complex with trypsin in vivo and in vitro. Scand J Clin Lab Invest 1978; 38: 507–15
   PubMed Web of Science ®Google Scholar
• Marks W H, Ohlsson K. Elimination of pancreatic secretory trypsin inhibitor from the circulation. A study in man. Scand J Gastroenterol 1983; 18: 955–9
   PubMed Web of Science ®Google Scholar
• Nick H P, Probst A, Schnebli H P. Development of Eglin c as a drug: pharmacokinetics. Potential Role in Health and Disease, W H Horl, A Heidland. Plenum Press, New York 1989; 83–8
   Google Scholar
• Egbring R, Schmidt W, Fuchs G, Havemann K. Demonstration of granulocyte proteases in plasma of patients with acute leukemia and septicemia with coagulation defects. Blood 1977; 49: 219–31
   PubMed Web of Science ®Google Scholar
• Aasen A O, Ohlsson K. Release of granulocyte elastase in lethal canine endotoxin shock. Hoppe-Seyler's Z Physiol Chem 1978; 359: 683–90
   PubMedGoogle Scholar
• Fritz H. Proteinase inhibitors in severe inflammatory processes (septic shock and experimental endotoxemia): biochemical, pathophysiological and therapeutic aspects. Protein Degradation in Health and Disease, D Evered, J Whelen. Excerpta Medica, Amsterdam 1980; 351–79
   Google Scholar
• Jochum M, Witte J, Schliesser H. Clotting and other plasma factors in experimental endotoxemia: inhibition of degradation by exogenous proteinase inhibitors. Eur Surg Res 1981; 13: 152–68
   PubMed Web of Science ®Google Scholar
• Jochum M, Welter H F, Siebeck M, Fritz H. Proteinase inhibitor therapy of severe inflammation in pigs: first results with Eglin, a potent inhibitor of granulocyte elastase and dathepsin G. Proteinases in Inflammation and Tumor Invasion, H Tschesche. Walter de Gruyter, Berlin 1986; 53–9
   Google Scholar